BRPI0911372A2 - sulfato de condroitina formado por dissacarídeos não saturados sulfatados na proteção e no reparo de tecido conjuntivo - Google Patents

sulfato de condroitina formado por dissacarídeos não saturados sulfatados na proteção e no reparo de tecido conjuntivo

Info

Publication number
BRPI0911372A2
BRPI0911372A2 BRPI0911372A BRPI0911372A BRPI0911372A2 BR PI0911372 A2 BRPI0911372 A2 BR PI0911372A2 BR PI0911372 A BRPI0911372 A BR PI0911372A BR PI0911372 A BRPI0911372 A BR PI0911372A BR PI0911372 A2 BRPI0911372 A2 BR PI0911372A2
Authority
BR
Brazil
Prior art keywords
repair
protection
connective tissue
chondroitin sulfate
sulfate formed
Prior art date
Application number
BRPI0911372A
Other languages
English (en)
Inventor
Delphine Tissot-Favre
Laurent Ameye
Sean Christopher Austin
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39645693&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0911372(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0911372A2 publication Critical patent/BRPI0911372A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0911372A 2008-04-02 2009-03-26 sulfato de condroitina formado por dissacarídeos não saturados sulfatados na proteção e no reparo de tecido conjuntivo BRPI0911372A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08153937A EP2106798A1 (en) 2008-04-02 2008-04-02 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair
PCT/EP2009/002226 WO2009121519A1 (en) 2008-04-02 2009-03-26 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair

Publications (1)

Publication Number Publication Date
BRPI0911372A2 true BRPI0911372A2 (pt) 2015-12-29

Family

ID=39645693

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911372A BRPI0911372A2 (pt) 2008-04-02 2009-03-26 sulfato de condroitina formado por dissacarídeos não saturados sulfatados na proteção e no reparo de tecido conjuntivo

Country Status (10)

Country Link
US (1) US20110028400A1 (pt)
EP (2) EP2106798A1 (pt)
CN (1) CN102046182A (pt)
AR (1) AR071356A1 (pt)
AU (1) AU2009231154A1 (pt)
BR (1) BRPI0911372A2 (pt)
CL (1) CL2009000798A1 (pt)
MX (1) MX2010010718A (pt)
SG (1) SG188936A1 (pt)
WO (1) WO2009121519A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20120896A1 (it) * 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
ITMI20121316A1 (it) * 2012-07-27 2014-01-28 Altergon Sa Complessi di condroitina ad assorbimento transcutaneo
WO2015070386A1 (zh) * 2013-11-13 2015-05-21 青岛贝尔特生物科技有限公司 一种预防中老年人骨关节疾病的膳食营养补充剂
CN103609940A (zh) * 2013-11-21 2014-03-05 青岛贝尔特生物科技有限公司 一种供心肌炎患者食用含硫酸软骨素二糖的食品配方
GB201414910D0 (en) * 2014-05-23 2014-10-08 Mars Inc Composition
US20170239286A1 (en) * 2014-06-11 2017-08-24 International Scientific Pty Ltd. Device and method to treat or prevent joint degeneration
IT201600079773A1 (it) * 2016-07-29 2018-01-29 Matteo Bevilacqua Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4693014B2 (ja) * 2001-03-08 2011-06-01 蓮井 昌彦 グリコサミノグリカン二糖の製造方法。
KR20030046810A (ko) * 2001-12-06 2003-06-18 은삼제약 주식회사 콘드로이친 황산의 분해산물을 포함하는 관절염 예방 또는치료용 약학적 조성물
ES2374157T3 (es) * 2002-10-16 2012-02-14 Arthrodynamic Technologies, Animal Health Division, Inc. Tratamiento para la sinovitis traumática y el cartílago articular dañado.

Also Published As

Publication number Publication date
WO2009121519A8 (en) 2010-12-09
EP2106798A1 (en) 2009-10-07
AR071356A1 (es) 2010-06-16
CN102046182A (zh) 2011-05-04
MX2010010718A (es) 2010-12-21
CL2009000798A1 (es) 2010-05-07
AU2009231154A1 (en) 2009-10-08
US20110028400A1 (en) 2011-02-03
SG188936A1 (en) 2013-04-30
WO2009121519A1 (en) 2009-10-08
EP2282743A1 (en) 2011-02-16

Similar Documents

Publication Publication Date Title
BRPI0911372A2 (pt) sulfato de condroitina formado por dissacarídeos não saturados sulfatados na proteção e no reparo de tecido conjuntivo
BRPI0920808A2 (pt) hipersustentador disposto na área de sustenção de uma aeronave
BRPI0817493A2 (pt) Fibras de uhmwpe e um processo para produzir as mesmas
BRPI0822802A2 (pt) Biomaterial na forma de hidrogel injetável, biomaterial derivado do cordão umbilical humano, processo para a obtenção do biomaterial, processo para a obtenção do biomaterial obtido e uso do biomaterial
BR112012000391A2 (pt) expressão de representação visual baseada na expressão do jogador
BRPI0910045A2 (pt) composições de absorção de sebo
BRPI0807340A2 (pt) tampões externos (punctal) e métodos de envio de agentes terapêuticos
BRPI0921946A2 (pt) gerador de onda de gravidade de superfície e piscina de onda
BRPI0908265A2 (pt) Composição de limpeza que proporciona vantagens residuais
DE602006015768D1 (de) Teilchenstrahlgerät mit Ozon-Quelle
BRPI0806571A2 (pt) Fralda com painéis extensores de quadris
BRPI0819281A2 (pt) Composições de fibra inorgânica
BRPI0716397A2 (pt) mÉtodos para identificar agentes que promovem a osteogÊnese e para promover a osteogÊnese em uma cÉlula de mamÍfero.
BR112012008202A2 (pt) processo de preparação de uma composição, componentes e uso da composição
BRPI0907062A2 (pt) "hidrociclone"
BRPI0911848A2 (pt) reparo do ângulo assistido por balão
BR112012004668A2 (pt) "composição e processo"
EP2349325A4 (en) PROTECTION AND REPAIR OF CARTEL AND MUSCULAR CELETALS SOFT-TISSUE
BRPI0922203A2 (pt) autoprecipitação de composição particulada aquosa que compreende partículas de pigmento-aglutinante
BRPI0918579A2 (pt) composição de gel tensoativa
ITMI20051416A1 (it) Composizioni cosmetiche contenenti acido ialuronico e colostro
BR112013027389A2 (pt) sulfato de condroitina biotecnológico sulfatado na posição 4 ou 6 na mesma cadeia polissacarídica e processo para seu preparo
BRPI0905885A2 (pt) "processo de preparação de uma composição que contém polímero, composição e uso da composição"
FR2905513B1 (fr) Commutateur inverseur
HUE050574T2 (hu) Készítmények és módszerek kötõszövet gyógyulás indukálására vagy elõsegítésére

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.